Skip to content

Endopath Surgical Instruments

by Symbiosis Corp.

510(k) K910831

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK910831 Date31 May 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEI
Device Class
Class II
Regulation
21 CFR Part 878.4400
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Endopath Surgical Instruments are classified as electrosurgical devices designed for tissue dissection, coagulation, and fluid evacuation during surgical procedures. These instruments utilize electrosurgery principles to provide precise control over tissue manipulation, supporting minimally invasive and laparoscopic techniques in general and plastic surgery applications.

Supplied as a reusable system, these instruments are intended for use in controlled surgical environments. The device holds an FDA 510(k) clearance (K910831) under the product code GEI, with a historical submission date of February 27, 1991. Sterility and maintenance protocols must adhere to manufacturer guidelines to ensure safe, repeated use in clinical settings.

Other devices from Symbiosis Corp.

See all devices from Symbiosis Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are the Endopath Surgical Instruments designed for single-use or can they be reused in multiple procedures?

    The Endopath Surgical Instruments are supplied as a reusable system, meaning they are intended for repeated use in controlled surgical environments. To maintain safety and performance, they must follow the manufacturer’s sterility and maintenance protocols after each use.

  • What types of surgical procedures are these instruments primarily used for?

    These instruments are designed for tissue dissection, coagulation, and fluid evacuation during surgical procedures, particularly supporting minimally invasive and laparoscopic techniques. They are classified under the General and Plastic Surgery advisory committee and are suitable for those applications.

  • How are the Endopath Surgical Instruments regulated in the U.S.?

    The Endopath Surgical Instruments hold an FDA 510(k) clearance (K910831) under the product code GEI, with a historical submission date of February 27, 1991. This clearance indicates they are deemed substantially equivalent to a legally marketed device, allowing their use in controlled surgical environments.

  • What kind of electrosurgery principles do these instruments utilize?

    The Endopath Surgical Instruments use electrosurgery principles to provide precise control over tissue manipulation, enabling dissection, coagulation, and fluid evacuation during surgery. This technology supports minimally invasive and laparoscopic procedures in general and plastic surgery.